In his book PiHKAL, the dosage is listed as 150–250 mg, and the duration listed as 3–5 hours. According to Shulgin, EDMA produces a bare threshold consisting of paresthesia, nystagmus, and hypnogogic imagery, with few to no other effects. Scientific research has demonstrated that EDMA acts as a non-neurotoxic serotonin releasing agent with moderately diminished potency relative to MDMA, and with negligible effects on dopamine release.
In his book PiHKAL, the dosage is specified as 150–250 mg, and the duration listed as 3–5 hours. According to Shulgin, EDMA creates a minimal effect consisting of tingling sensations, eye movements, and dreamlike imagery, with little to no additional impacts. Scientific research has shown that EDMA functions as a non-toxic serotonin releaser with slightly reduced potency compared to MDMA, and it produces negligible dopamine release.